TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients

E. Manali (Athens, Greece), C. Kannengiesser (Paris, France), L. Kolilekas (Athens, Greece), I. Korbila (Athens, Greece), G. Papadaki (Athens, Greece), M. Kallieri (Athens, Greece), P. Giouleka (Athens, Greece), A. Papaioannou (Athens, Greece), I. Tomos (Athens, Greece), E. Stagaki (Athens, Greece), A. Papaporfyriou (Athens, Greece), A. Karakatsani (Athens, Greece), S. Loukides (Athens, Greece), K. Kagouridis (Athens, Greece), V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), K. Antoniou (Heraklion, Greece), A. Trachalaki (Heraklion, Greece), A. Markopoulou (Thessaloniki, Greece), Z. Daniil (Larissa, Greece), E. Fouka (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), A. Xyfteri (Messini Messinias, Greece), A. Gogali (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), P. Steiropoulos (Komotini, Greece), I. Papanikolaou (Corfu , Greece), C. Bazaka (Agrinio, Aetolia-Acarnania , Greece), A. Charitou (Ioannina , Greece), M. Maniati (Ioannina , Greece), P. Lyberopoulos (Athens, Greece), K. Vlami (Athens, Greece), T. Raptakis (Athens, Greece), P. Revy (Paris, France), M. Gaga (Athens , Greece), P. Dieude (Paris, France), N. Nathan (Paris, France), R. Borie (Paris, France), C. Boileau (Paris, France), D. Bouros (Athens, Greece), B. Crestani (Paris, France), S. Papiris (Athens, Greece), (Athens, Greece)

Source: International Congress 2018 – Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Session: Idiopathic interstital pneumonias other than idiopathic pulmonary fibrosis (IPF)
Session type: Thematic Poster
Number: 2939
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Manali (Athens, Greece), C. Kannengiesser (Paris, France), L. Kolilekas (Athens, Greece), I. Korbila (Athens, Greece), G. Papadaki (Athens, Greece), M. Kallieri (Athens, Greece), P. Giouleka (Athens, Greece), A. Papaioannou (Athens, Greece), I. Tomos (Athens, Greece), E. Stagaki (Athens, Greece), A. Papaporfyriou (Athens, Greece), A. Karakatsani (Athens, Greece), S. Loukides (Athens, Greece), K. Kagouridis (Athens, Greece), V. Tzilas (Athens, Greece), A. Tzouvelekis (Athens, Greece), E. Bouros (Athens, Greece), K. Antoniou (Heraklion, Greece), A. Trachalaki (Heraklion, Greece), A. Markopoulou (Thessaloniki, Greece), Z. Daniil (Larissa, Greece), E. Fouka (Thessaloniki, Greece), D. Papakosta (Thessaloniki, Greece), A. Xyfteri (Messini Messinias, Greece), A. Gogali (Ioannina, Greece), A. Konstantinidis (Ioannina, Greece), P. Steiropoulos (Komotini, Greece), I. Papanikolaou (Corfu , Greece), C. Bazaka (Agrinio, Aetolia-Acarnania , Greece), A. Charitou (Ioannina , Greece), M. Maniati (Ioannina , Greece), P. Lyberopoulos (Athens, Greece), K. Vlami (Athens, Greece), T. Raptakis (Athens, Greece), P. Revy (Paris, France), M. Gaga (Athens , Greece), P. Dieude (Paris, France), N. Nathan (Paris, France), R. Borie (Paris, France), C. Boileau (Paris, France), D. Bouros (Athens, Greece), B. Crestani (Paris, France), S. Papiris (Athens, Greece), (Athens, Greece). TERT/TERC mutations in a Greek cohort of suspected genetic pulmonary fibrosis patients. 2939

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Telomere-Related Gene mutations in a Greek cohort of suspected monogenic pulmonary fibrosis patients
Source: Virtual Congress 2020 – Idiopathic pulmonary fibrosis and interstitial lung disease: progression, genes and more
Year: 2020


MUC5B gene in a cohort of Lebanese patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – News on the diagnosis of idiopathic interstitial pneumonia
Year: 2018

Healthy survivor bias in patients with idiopathic pulmonary fibrosis in clinical registries.
Source: Virtual Congress 2021 – News in treatment and diagnosis of idiopathic interstitial pneumonia
Year: 2021


Effect of MUC5B gene polymorphism on survival in a Lebanese population of patients with idiopathic pulmonary fibrosis
Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs)
Year: 2018

Survival predictors in a cohort of patients with idiopathic pulmonary fibrosis biopsy-proven
Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV
Year: 2012


Combined pulmonary fibrosis and emphysema characteristics in a Greek cohort
Source: ERJ Open Res, 5 (1) 00014-2018; 10.1183/23120541.00014-2018
Year: 2019



Longitudinal observation of idiopathic pulmonary fibrosis (IPF) patients cohort from one center in Poland.
Source: International Congress 2019 – Interstitial lung disease registries
Year: 2019

The diagnosis of cystic fibrosis in adult COPD patients. A survey of 54 patients
Source: Eur Respir J 2001; 18: Suppl. 33, 215s
Year: 2001

Occupational risk factors and idiopathic pulmonary fibrosis. A case-control study
Source: Annual Congress 2007 - The air we breathe at home and at work
Year: 2007


Novel rare genetic variants in idiopathic pulmonary fibrosis
Source: Eur Respir J, 56 (6) 2003252; 10.1183/13993003.03252-2020
Year: 2020



Mid-term clinical course of the three Japanese SFTPC mutated familial interstitial pneumonia patients.
Source: International Congress 2018 – New insights in rare diffuse parenchymal lung diseases (DPLDs) in adults and children
Year: 2018



Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
Source: ERJ Open Res, 3 (1) 00056-2016; 10.1183/23120541.00056-2016
Year: 2017



Screening for cystic fibrosis among high risk group patients with chronic lung disease
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Genetic susceptibility and pulmonary fibrosis
Source: Annual Congress 2005 - Idiopathic pulmonary fibrosis: new concepts in its pathogenesis and management
Year: 2005

Baseline characteristics and survival of patients with idiopathic pulmonary fibrosis (IPF): analysis from the Swedish IPF registry
Source: Virtual Congress 2020 – Real life in the field of idiopathic pulmonary fibrosis: treatments and registries
Year: 2020


Idiopathic pulmonary fibrosis (IPF) patients in Poland – preliminary cohort analysis of EMPIRE registry
Source: International Congress 2017 – ILDs: clinical aspects
Year: 2017

The genetic basis of idiopathic pulmonary fibrosis
Source: Eur Respir J 2015; 45: 1717-1727
Year: 2015



Central European idiopathic pulmonary fibrosis (IPF) patients survey
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

Registry of idiopathic pulmonary fibrosis patients
Source: International Congress 2016 – Russia Session
Year: 2016

Early markers of cystic fibrosis structural lung disease: follow-up of the ACFBAL cohort
Source: Eur Respir J, 55 (4) 1901694; 10.1183/13993003.01694-2019
Year: 2020